ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

Biotechnology

ImmunoGenesis

ImmunoGenesis' headquarters in Houston, TX, United States

Jim Barlow

Matt H.

Federica O’Brien

Federica Pericle

Thomas U. Barton

Ted Koutouzis

Robert B. Stein

Clifford Stocks

Darryl Patrick

Taha Merghoub

Ingunn Stromnes

Xingxing Zang

Lawrence Fong

David S. Hong

The Scientific Advisory team at ImmunoGenesis provides expert guidance on the development and optimization of immune therapies aimed at enhancing anti-tumor immunity. This team conducts rigorous evaluations of scientific data, contributes to strategic planning, and collaborates with research teams to ensure that therapies are both innovative and aligned with the latest advancements in immunology. Their collective expertise helps shape the direction of the company’s research and development efforts.

Scientific Advisory

The Leadership Team at ImmunoGenesis is responsible for setting the strategic direction and overseeing the development of innovative immune therapies. Comprising key executives and founders, the team evaluates clinical progress, fosters scientific collaboration, and ensures alignment with the company's mission to overcome immune resistance in tumors. Their collective expertise drives decision-making to advance research and bring novel treatments to market.

Leadership Team

The Research & Development team at ImmunoGenesis is dedicated to advancing innovative immune therapies aimed at treating tumors with low T cell activation or immune resistance. This team collaborates across disciplines to design, conduct, and analyze preclinical studies, ensuring that new therapies are scientifically robust and aligned with quality standards for future clinical applications.

Research & Development

This department provides strategic direction and governance for the organization.

Leadership Council

This department oversees the management and execution of clinical trials and related operational processes.

Clinical Operations

This department is responsible for overseeing and managing investment portfolios, conducting financial analysis, and supporting investor relations.

ImmunoGenesis

Org chart

Board & advisors

Teams

Scientific Advisory

Leadership Team

Research & Development

Leadership Council

Clinical Operations

Investment Management

Offices

ImmunoGenesis

Org chart

Board & advisors

Teams

Scientific Advisory

Leadership Team

Research & Development

Leadership Council

Clinical Operations

Investment Management

Offices

Related companies